Validation of T-Track® CMV to assess the functionality of cytomegalovirus-reactive cell-mediated immunity in hemodialysis patients
about
An optimized IFN-γ ELISpot assay for the sensitive and standardized monitoring of CMV protein-reactive effector cells of cell-mediated immunity.Immunological Prediction of Cytomegalovirus (CMV) Replication Risk in Solid Organ Transplantation Recipients: Approaches for Regulating the Targeted Anti-CMV Prevention Strategies.Clinical validation of a novel ELISpot-based in vitro diagnostic assay to monitor CMV-specific cell-mediated immunity in kidney transplant recipients: a multicenter, longitudinal, prospective, observational study.Diagnostic utility of monitoring cytomegalovirus-specific immunity by QuantiFERON-cytomegalovirus assay in kidney transplant recipients.Assessment of the T-SPOT.CMV interferon-γ release assay in renal transplant recipients: A single center cohort study.
P2860
Validation of T-Track® CMV to assess the functionality of cytomegalovirus-reactive cell-mediated immunity in hemodialysis patients
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Validation of T-Track® CMV to ...... unity in hemodialysis patients
@ast
Validation of T-Track® CMV to ...... unity in hemodialysis patients
@en
type
label
Validation of T-Track® CMV to ...... unity in hemodialysis patients
@ast
Validation of T-Track® CMV to ...... unity in hemodialysis patients
@en
prefLabel
Validation of T-Track® CMV to ...... unity in hemodialysis patients
@ast
Validation of T-Track® CMV to ...... unity in hemodialysis patients
@en
P2093
P2860
P1433
P1476
Validation of T-Track® CMV to ...... unity in hemodialysis patients
@en
P2093
Anne Rascle
Bernd Krüger
Bernhard Banas
Bernhard K Krämer
Carsten A Böger
Gerhard Lückhoff
Hanna Bendfeldt
Joachim Leicht
Josef Köstler
Julia Batzilla
P2860
P2888
P356
10.1186/S12865-017-0194-Z
P577
2017-03-07T00:00:00Z
P6179
1084250117